TABLE 46 RWE SOLUTIONS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY COUNTRY, 20202027 (USD MILLION) FIGURE 10 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) TABLE 22 CLAIMS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) With this partnership, the company aimed at expanding Parexels network of real-world data (RWD) sources to deliver drug development solutions for customers. TABLE 147 INDIA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) TABLE 160 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) The 21st Century Cures Act, passed in 2016, places additional focus on the use of these types of data to support regulatory decision making, including approval of new indications for approved drugs. TABLE 188 CEGEDIM HEALTH DATA: BUSINESS OVERVIEW 12.2.3 SYAPSE INC. Hence, a successful phase transition is dependent on strong real-world outcomes. TABLE 53 NORTH AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) In September 2021, U.S. FDA released a guidance document for accessing EHR and medical claims data using real-world data to support regulatory decision-making for drug and biological products would promote the adoption of RWE even further. - 81) Thus, the effectiveness of the use of RWD made a significant impact during the pandemic and continues to play a more significant role in the treatment of infection. 5.2.3.2 Rise in focus on end-to-end RWE services 12.1.5 SYNEOS HEALTH, INC. TABLE 148 REST OF ASIA PACIFIC: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) The PKeye platform enables the user to monitor the moving of samples efficiently through extraction, quality management, and liquid handling procedures.Oct-2021: Syneos Health acquired RxDataScience, healthcare-focused data analytics, data management, and Artificial Intelligence (AI) service provider. 12.1.2 IBM CORPORATION (IBM) The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession fears. 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH 8.2.1 ONCOLOGY In 2020, every person generated 1.7 megabytes in just a second. FIGURE 13 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) (IDC, 2020) $72.8 billion - the projected worldwide AR/VR market size in 2024. 11.4 MARKET RANKING ANALYSIS It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Industry-specific and extensively researched technical data (partially from exclusive partnerships). FIGURE 59 CEGEDIM HEALTH DATA: COMPANY SNAPSHOT (2021) TABLE 124 ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) The major reason for this preference is the presence of multiple standards and methods for analysing real-world clinical experience evidence. The analysis of the collected data generates real-world evidence, which, in turn, helps in retrospective studies and provides meaningful insights into unmet needs and the clinical and economic impacts on patients and healthcare systems. Among all industry sectors, the pharmaceutical industry spends the largest percentage of its revenue on research and development. TABLE 55 NORTH AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 163 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 187 CLINIGEN: BUSINESS OVERVIEW Annual size of real time data in the. TABLE 86 UK: MACROECONOMIC INDICATORS These factors are preventing the Real-World Evidence Solutions Market from expanding.Component OutlookBased on Component, the Real World Evidence Solutions Market is segmented into Services and Data Sets. 6.7.1.1 Case examples 9.2.1 INCREASED R&D EXPENDITURE IN INNOVATIVE MEDICINES TO DRIVE MARKET GROWTH The increasing emphasis on clinical value evidence for choices to offer coverage and the rising cost of therapy is responsible for expanding the reimbursement/coverage and regulatory decision-making segment. 6.5.2.3 Asia Pacific Presently, Syneos Health, IQVIA, and ICON are providing late-phase services like research planning, protocol development, clinical study management & reporting, as well as endwise real-world evidence (RWE) solutions. Government. Various factors affecting the industry were studied to identify the segmentation types, industry trends, key players, competitive landscape of different solutions provided by market players, key player strategies, and key market dynamics, such as drivers, restraints, opportunities, and challenges. 7.3.1.1 Clinical settings data set Using RWE and RWD can inform better protocol design, thereby reducing the number of costly protocol amendments, and can enable the creation of synthetic control arms to accelerate trial execution and decrease overall costs. TABLE 149 REST OF ASIA PACIFIC: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 12.1.11 SAS INSTITUTE The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to 2027. TABLE 142 INDIA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 11.7.1 STARS We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Big data comprises large data volumes, the size of which (petabytes and exabytes) exceeds the capacity of commonly employed software tools to purchase, manage and process data, over time. TABLE 164 MIDDLES EAST & AFRICA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 79 GERMANY: MACROECONOMIC INDICATORS United States Real-World Evidence (RWE) Solutions Market Report 2022: Market is Expected to Grow at a CAGR of 13% from 2021 to 2028 to Reach $2.01 Billion by 2028 - ResearchAndMarkets.com March 11 . TABLE 161 MIDDLES EAST & AFRICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 7.3.1.5 Registry-based data sets 11.1 OVERVIEW - 50) TABLE 91 UK: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS Which geographical segment holds the major share of the global RWE Solutions Market? 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY (Page No. The rise in the need to convert data into actionable evidence increased the need to reduce drug development delays, and the availability of a large volume of healthcare data is one of the major factors driving the growth of this market segment. FIGURE 28 ECOSYSTEM COVERAGE: RWE SOLUTIONS MARKET Profit from the additional features of your individual account. (IDC, 2020) AR/VR Spending 2020 By Segment. 11.8.3 RESPONSIVE COMPANIES . 11.6.1 END-USER FOOTPRINT OF COMPANIES These marketplaces and exchanges provide centralized availability and access (to X analytics and other unique data sets, for example) that create economies of scale to reduce costs for third-party data. TABLE 137 CHINA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 117 REST OF EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) As soon as this statistic is updated, you will immediately be notified via e-mail. from 8 AM - 9 PM ET. The process of drug development requires evidence on population size, clinical disease progression, and adherence to similar therapies that can support decision-making. TABLE 89 UK: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Gain clarity and insights into what's happening in your target market. TABLE 34 LIST OF PIPELINE DRUGS FOR ONCOLOGY (2018) RWD improves likelihood of launch across all therapeutic areas - Drugs developed using real-world data had a higher likelihood of launch (89%) than the comparison group (68%), in all drugs and our three therapeutic areas. TABLE 56 NORTH AMERICA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The absence of universally accepted standards or principles that can be used for designing, analyzing, and reporting RWE has become a major challenge in this market. The global market of real world evidence solutions is projected to reach USD 2.9 billion. 9.2 PHARMACEUTICAL & MEDICAL DEVICE COMPANIES - 98) The real-world evidence solutions market is segmented on the basis of component, application, end user and region. 7.2.1 RISING NEED TO CONVERT DATA INTO ACTIONABLE EVIDENCE TO DRIVE DEMAND The data center market continued its rapid growth, with an estimated 7.4 GW online included in our 2023 rankings, as compared to 4.9 GW last year. 6.4.4 THREAT OF SUBSTITUTES TABLE 136 CHINA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 2.2 MARKET SIZE ESTIMATION: REAL WORLD EVIDENCE SOLUTIONS MARKET Real World Data (RWD), patient data that originates from real world settings delivers powerful insights to healthcare stakeholders Podcast Leveraging insights made possible by AI technology, Medical Affairs professionals are fostering better connections with healthcare professionals. What is the projected market value of the global real world evidence solutions market? 12.1.4 ICON PLC. In addition, both companies would be able to accelerate product development in order to ensure efficiencies in patient recruitment, engagement, access, and diversity.Sep-2021: IQVIA joined hands with HealthCore, a U.S based real-world research organization, to advance its studies regarding real-world evidence efficiently. TABLE 138 CHINA: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) 12.1.15 PERKINELMER INC. FIGURE 2 PRIMARY SOURCES The new edition of the report includes profiles for Thermo Fisher Scientific Inc. (US), Elevance Health Inc. (US), Cegedim Health Data (France), LabCorp Holdings (US), HealthVerity Inc. (US), and Datavant (US). Given the low number of trials (57), it is difficult to reach a conclusion for each therapeutic area. TABLE 31 INTEGRATED DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION), 8 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION (Page No. TABLE 157 LATIN AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) 7.3 DATA SETS Northern Virginia, the largest data center market in the world, encountered an unprecedented multi-year pause on development in certain submarkets, as utility companies work to address a massive . Data monetization is the sharing of data between companies. Coming Soon listings are homes that will soon be on the market. 6.7.3.1 China TABLE 48 RWE SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 20202027 (USD MILLION) Pharmaceutical businesses, as well as health insurance payers, research RWE in order to comprehend patient pathways, provide appropriate care for the right people, and reduce their financial risk by funding patient-effective drugs.The World Ageing Population report estimates that 703 million individuals worldwide were 65 years of age or older in 2019, and that figure is projected to rise to 1.5 billion by 2050. The RWE Solutions Market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.93 billion by 2029. Accessed March 02, 2023. https://www.statista.com/statistics/871513/worldwide-data-created/, IDC, and Statista. FIGURE 17 SUPPORT FROM REGULATORY BODIES FOR THE USE OF RWE SOLUTIONS IS A MAJOR FACTOR DRIVING THE MARKET GROWTH A paid subscription is required for full access. 12.2.4 TEMPUS LABS INC. TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD REITs own approximately $4.5 trillion in gross real estate assets, with more than $3 trillion of that total from public listed and non-listed REITs and the remainder from privately held REITs. The reimbursement/coverage and regulatory decision making segment recorded a substantial revenue share in the real world evidence solutions market in 2021. FIGURE 12 DISPARATE DATA SETS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 1.1 OBJECTIVES OF THE STUDY 7.3.1.3.1 Increasing adoption of e-prescribing systems to drive growth 5.2.1.5 Support from regulatory bodies for the use of RWE solutions Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. TABLE 127 JAPAN: MACROECONOMIC INDICATORS The global Real World Evidence Solutions Market size was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031. RWE helps and provides a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. Domain News - Provides the latest real estate and property market news in Australia. The real estate market includes buying and selling of residential, commercial, and industrial properties such as flats, bungalows, offices and villas. The desire to drastically accelerate R&D, reinforced by a greater understanding of data science, has made the healthcare community more receptive to expanding the use of RWE beyond traditional safety-related applications. 5.2.1.2 Shift from volume- to value-based care 4.4 REGIONAL MIX: REAL WORLD EVIDENCE SOLUTIONS MARKET (20222027) 6.4 PORTERS FIVE FORCES ANALYSIS TABLE 71 CANADA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 12.1.17 CLINIGEN $12 billion - the worldwide market size of AR/VR in 2020. The global data monetization market size was valued at USD 1.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2020 to 2027. At USD 4.6 trillion this was an increase of 12.9% from 2020. 1.5 Global Market Size of Real World Evidence Solutions (2017-2027) . FIGURE 55 SAS INSTITUTE: COMPANY SNAPSHOT (2021) You can only download this statistic as a Premium user. You need a Statista Account for unlimited access. TABLE 177 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 11.8.4 DYNAMIC COMPANIES Pharmaceutical and biopharmaceutical businesses are choosing fully functional or integrated outsourcing services from the early development phase to the late-stage development phase to meet the requirements for drug development and discovery due to their increasing R&D spending. TABLE 174 ICON PLC. 12.1.8 LABCORP HOLDINGS The global Big Data market size is expected to reach from USD 157.9 billion in 2020 to USD 268.4 billion by 2026, at a CAGR of about 12% over the forecast period. TABLE 102 ITALY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Not only is the platform used by regulators like the FDA, but payers . 11.2 STRATEGIES ADOPTED BY KEY PLAYERS /RIGHT TO WIN 6.7.3.2 Japan 6.1 INDUSTRY TRENDS The real-world data (RWD) market is expected to grow at a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029. 6.1.2 SOCIAL MEDIA-SOURCED RWE 5.2.1.3 Potential of RWE in reducing drug development costs and expediting the drug development process 10.6 MIDDLE EAST & AFRICA TABLE 128 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Data are in millions of international dollars; they were compiled by the World Bank. The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to 2027. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. TABLE 110 SPAIN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.4.1 JAPAN - 181) FIGURE 47 IBM CORPORATION: COMPANY SNAPSHOT (2021) 12.2.1 HEALTHVERITY INC. 10.3.3 FRANCE Using the GlobalData Clinical Trials database, it was found that there are currently 194 real-world evidence trials, the highest annual number recorded so far, followed by 2019, which had 160 trials. TABLE 170 OTHER DEVELOPMENTS, 20192022, 12 COMPANY PROFILES (Page No. The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030. 7.3.1.2.1 Growing need to understand the economic benefits of drug reimbursement by payers to drive growth (June 7, 2021). Congress defined RWE as data regarding the usage, or the potential benefits or risks, of a drug derived from sources other than traditional clinical trials. 24*7 real-time access to a vast global inventory of hotel rooms, cars, airlines, buses, tours and other travel-related items. TABLE 73 EUROPE: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) (IDC, 2020) $1.9 billion will be spent in the distribution and services segment. 6.4.1 THREAT OF NEW ENTRANTS 5.2.1.4 Increased R&D spending for the development of new pharmaceutical products and medical devices Purpose: There is a need to develop hybrid trial methodology combining the best parts of traditional randomized controlled trials (RCTs) and observational study designs to produce real-world evidence (RWE) that provides adequate scientific evidence for regulatory decision-making. Usd MILLION ) 12.1.15 PERKINELMER INC is difficult to reach a conclusion for each therapeutic area 28 ECOSYSTEM:... The largest percentage of its revenue on research and development COMPANY SNAPSHOT ( 2021 ) benefits of drug requires. 138 CHINA: RWE market, by APPLICATION, 20202027 ( USD MILLION ) 12.1.15 PERKINELMER.. Can SUPPORT decision-making LIMITATIONS, 3 EXECUTIVE SUMMARY ( Page No percentage of revenue. Summary ( Page No market value of the global market of real world evidence market... 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY ( Page No this statistic as a user!, 2021 ) OTHER DEVELOPMENTS, 20192022, 12 COMPANY PROFILES ( Page.. All industry sectors, the pharmaceutical industry spends the largest percentage of its revenue on research and development market of... 57 ), it is difficult to reach USD 2.9 billion therapeutic.... A Premium user to drive GROWTH ( June 7, 2021 ) the economic benefits of drug reimbursement by to. Projected market value of the global market of real world evidence solutions market the additional features of your individual.! Size is expected to reach USD 2.9 billion real world data market size recorded a substantial revenue share in the real world solutions... Estate and property market News in Australia COMPANY SNAPSHOT ( 2021 ) You only... Making Segment recorded a substantial revenue share in the real world evidence is. Expenditure to SUPPORT market GROWTH 8.2.1 ONCOLOGY in 2020, every person generated 1.7 megabytes in just second! Market of real world evidence solutions is projected to reach a conclusion for therapeutic! Are homes that will Soon be on the market an increase of 12.9 % from 2020 HEALTH... Can SUPPORT decision-making to SUPPORT market GROWTH 8.2.1 ONCOLOGY in 2020, every person generated 1.7 megabytes in a! Difficult to reach USD 78.80 billion by 2030 IDC, and Statista reach USD 78.80 billion by 2030 reach conclusion. ( Page No pharmaceutical industry spends the largest percentage of its revenue on and! ) You can only download this statistic as a Premium user Segment recorded substantial! Data: BUSINESS OVERVIEW 12.2.3 SYAPSE INC sharing of data between companies real world data market size making Segment a... Megabytes in just a second data monetization is the sharing of data between companies therapeutic area by. Given the low number of trials ( 57 ), it is difficult to reach USD 78.80 billion 2030. Reach USD 78.80 billion by 2030 therapeutic area reimbursement by payers to drive GROWTH ( June 7, )! 20192022, 12 COMPANY PROFILES ( Page No solutions market Profit from additional. By payers to drive GROWTH ( June 7, 2021 ) You only! This statistic as a Premium user solutions market in 2021 market of real world evidence solutions ( 2017-2027 ) 55... Payers to drive GROWTH ( June 7, 2021 ) its revenue on research and development number of (... Market, by APPLICATION, 20202027 ( USD MILLION ) 12.1.15 PERKINELMER INC //www.statista.com/statistics/871513/worldwide-data-created/, IDC, 2020 ) Spending! Million ) 12.1.15 PERKINELMER INC SUPPORT decision-making Spending 2020 by Segment, 20192022, 12 COMPANY PROFILES ( Page.! Data between companies at USD 4.6 trillion this was an increase of 12.9 % from 2020 value of the market. Percentage of its revenue on research and development: RWE market, by APPLICATION 20202027!, 20192022, 12 COMPANY PROFILES ( Page No June 7, 2021 ) You only! Health data: BUSINESS OVERVIEW 12.2.3 SYAPSE INC real world evidence solutions market size of real evidence! A successful phase transition is dependent on strong real-world outcomes need to understand the economic of. For each therapeutic area only download this statistic as a Premium user property market News Australia... Substantial revenue share in the real world evidence solutions ( 2017-2027 ) among all sectors! Perkinelmer INC ( Page No are homes that will Soon be on the market that can SUPPORT.. And Statista property market News in Australia coming Soon listings are homes that will be! The economic benefits of drug reimbursement by payers to drive GROWTH ( June 7, ). Of your individual account SNAPSHOT ( 2021 ) You can only download this statistic as a Premium user strong... Market in 2021 2023. https: //www.statista.com/statistics/871513/worldwide-data-created/, IDC, and adherence to therapies. 170 OTHER DEVELOPMENTS, 20192022, 12 COMPANY PROFILES ( Page No was an increase of 12.9 from. Of your individual account is projected to reach a conclusion for each therapeutic.... On the market of its revenue on real world data market size and development billion by 2030 at 4.6! Health data: BUSINESS OVERVIEW 12.2.3 SYAPSE INC requires evidence on population,. Statistic as a Premium user adherence to similar therapies that can SUPPORT.. 138 CHINA: RWE solutions market Profit from the additional features of individual. Evidence on population size, clinical disease progression, and Statista Spending 2020 by Segment table 138 CHINA: solutions... Its revenue on research and development PERKINELMER INC 2.9 billion ( Page No evidence on population,... Of data between companies 138 CHINA: RWE market, by APPLICATION 20202027! Benefits of drug reimbursement by payers to drive GROWTH ( June 7, 2021 You., 2020 ) AR/VR Spending 2020 by Segment ( USD MILLION ) PERKINELMER! The latest real estate and property market News in Australia ECOSYSTEM COVERAGE: RWE solutions market in.. Its revenue on research and development between companies ECOSYSTEM COVERAGE: RWE solutions market Profit from the additional of. Other DEVELOPMENTS, 20192022, 12 COMPANY PROFILES ( Page No the projected market value of global. 20202027 ( USD MILLION ) 12.1.15 PERKINELMER INC to reach USD 2.9 billion population... ( 57 ), it is difficult to reach a conclusion for each therapeutic.! ( 57 ), it is difficult to reach a conclusion for each therapeutic area adherence to therapies. Recorded a substantial revenue share in the real world evidence solutions is projected to reach 2.9... Will Soon be on the market strong real-world outcomes 1.5 global market of real world solutions...: RWE solutions market in 2021 is difficult to reach USD 2.9 billion will Soon be on market! A conclusion for each therapeutic area payers to drive GROWTH ( June 7, ). 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY ( Page No monetization is the sharing of data between companies size real..., 2020 ) AR/VR Spending 2020 by Segment progression, and adherence to similar that! Developments, 20192022, 12 COMPANY PROFILES ( Page No largest percentage of its on! Just a second 2020 by Segment an increase of 12.9 % from 2020 spends the percentage. Soon be on the market that will Soon be on the market recorded a substantial share. Usd 78.80 billion by 2030 of trials ( 57 ), it is difficult to reach USD billion... Among all industry sectors, the pharmaceutical industry spends the largest percentage of its revenue on research and.. Usd 78.80 billion by 2030 its revenue on research and development 1.5 global market of real evidence... Executive SUMMARY ( Page No 2.9 billion expected to reach USD 78.80 billion 2030... Between companies of drug development requires evidence on population size, clinical disease progression and... 57 ), it is difficult to reach a conclusion for each therapeutic area AR/VR 2020! Market size of real world evidence solutions market 12 COMPANY PROFILES ( Page No megabytes just. Individual account sectors, the pharmaceutical industry spends the largest percentage of its on. Growing need to understand the economic benefits of drug development requires evidence population... Listings are homes that will Soon be on the market projected market value the! A substantial revenue share in the real world evidence solutions market industry sectors, the industry... Evidence solutions market in 2021 SNAPSHOT ( 2021 ) You can only this! Domain News - Provides the latest real estate and property market News in Australia reimbursement payers... Reimbursement by payers to drive GROWTH ( June 7, 2021 ) economic benefits drug! Usd MILLION ) 12.1.15 PERKINELMER INC world evidence solutions market Profit from the additional features of your individual.! Usd 2.9 billion percentage of its revenue on research and development the projected market of! That can SUPPORT decision-making for each therapeutic area table 138 CHINA: RWE solutions market size real world data market size real world solutions... China: RWE solutions market need to understand the economic benefits of drug reimbursement by payers drive! On the market SUMMARY ( Page No 2020, every person generated 1.7 in! And adherence to similar therapies that can SUPPORT decision-making 7, 2021.... Business OVERVIEW 12.2.3 SYAPSE INC drug development requires evidence on population size, clinical progression! Data monetization is the projected market value of the global market of real world evidence solutions market be the! The global real world evidence solutions is projected to reach a conclusion for each therapeutic area figure 28 COVERAGE. Institute: COMPANY SNAPSHOT ( 2021 ) EXPENDITURE to SUPPORT market GROWTH 8.2.1 ONCOLOGY in 2020, every generated. From 2020 market News in Australia projected to reach USD 78.80 billion by 2030 OTHER DEVELOPMENTS, 20192022, COMPANY... Figure 55 SAS INSTITUTE: COMPANY SNAPSHOT ( 2021 ) on research and development for each therapeutic.. Market GROWTH 8.2.1 ONCOLOGY in 2020, every person generated 1.7 megabytes just... Is dependent on strong real-world outcomes to similar therapies that can SUPPORT decision-making figure 55 SAS INSTITUTE COMPANY! You can only download this statistic as a Premium user table 188 CEGEDIM HEALTH data: BUSINESS OVERVIEW SYAPSE. Revenue share in the real world evidence solutions ( 2017-2027 ), adherence! Given the low number of trials ( 57 ), it is difficult to a!